Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22,393 | 12,111 | 12,156 | 16,664 | 7,375 |
| TOTAL | $24,062 | $12,656 | $12,902 | $17,334 | $7,639 |
| Non-Current Assets | |||||
| PPE Net | 50 | 56 | 52 | 57 | 64 |
| Intangibles | 2,954 | 3,010 | 3,065 | 3,121 | 3,177 |
| Other Non-Current Assets | 551 | 736 | 628 | 566 | 612 |
| TOTAL | $3,555 | $3,802 | $3,745 | $3,744 | $3,853 |
| Total Assets | $27,617 | $16,458 | $16,647 | $21,078 | $11,492 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 129 | 165 | 196 | 203 | 198 |
| Accounts payable and accrued liabilities | 326 | 523 | 184 | 859 | 574 |
| Accrued Expenses | 1,393 | 1,122 | 1,164 | 1,807 | 2,367 |
| TOTAL | $1,848 | $1,810 | $1,544 | $2,869 | $3,139 |
| Non-Current Liabilities | |||||
| Long Term Debt | 94 | 110 | 118 | 159 | 212 |
| TOTAL | $94 | $110 | $118 | $159 | $212 |
| Total Liabilities | $1,942 | $1,920 | $1,662 | $3,028 | $3,351 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,618 | 3,587 | 1,876 | 1,568 | 418 |
| Common Shares | 74 | 51 | 43 | 41 | 19 |
| Retained earnings | -55,710 | -51,946 | -49,024 | -45,704 | -42,510 |
| Other shareholders' equity | 4 | 4 | 4 | 4 | 4 |
| TOTAL | $25,675 | $14,538 | $14,985 | $18,050 | $8,141 |
| Total Liabilities And Equity | $27,617 | $16,458 | $16,647 | $21,078 | $11,492 |